Healthcare company Healius (ASX:HLS) changed the terms of employment of Chief Executive Officer Paul Anderson, according to a Monday filing with the Australian bourse.
The CEO's tenure will now move to "permanent ongoing employment, subject to termination," from a fixed term ending June 30, 2026.
Anderson's fixed annual remuneration will also be increased to AU$1.3 million from AU$1.1 million, effective Jan. 1.
Further, the CEO's fiscal year 2027 bonus arrangements will include short- and long-term incentives to align with the remuneration structure for other key management personnel, pending performance measures, the filing said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.